Progressive multifocal leukoencephalopathy in a patient with primary amyloid light-chain amyloidosis-Reference-Cited by-同舟云学术

Progressive multifocal leukoencephalopathy in a patient with primary amyloid light-chain amyloidosis

Published:2020-05 Issue: Volume:192 Page:105709
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Katsuse Kazuto,Akiyama Kaho,Ishida Tadao,Kitayama Chigusa,Ishibashi Yoshitaka,Ochi Mieko,Kumasaka Toshio,Takahashi Kenta,Suzuki Tadaki,Nakamichi Kazuo,Saijo Masayuki^ORCID,Hashida Hideji

Funder

KAKENHI

Japan Society for the Promotion of Science

Grant-in-Aid for the Research Committee of Prion Disease and Slow Virus Infection

Japanese Ministry of Health, Labour and Welfare

Publisher

Elsevier BV

Subject

Clinical Neurology,General Medicine,Surgery

Reference5 articles.

1. Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death;Muchtar;Blood,2017

2. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section;Berger;Neurology,2013

3. Progressive multifocal leukoencephalopathy after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma treated with combination therapy;Yokokawa;J. Neurol. Sci.,2016

4. Lenalidomide-associated progressive multifocal leukoencephalopathy;Brigo;Leuk. Lymphoma,2017

5. Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis;Rodríguez-Lobato;Amyloid,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastics/immunosuppressants;Reactions Weekly;2020-03